Gilead Sciences to Present at Upcoming Investor Conference

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference:

Morgan Stanley Annual Global Healthcare Conference on Wednesday, September 15 at 12:30pm ET

The live webcast can be accessed at the company’s investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005966/en/

Jacquie Ross, Investors
(650) 358-1054

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• Japan Maritime Daily to Host International Shipping Seminar in Singapore on October 5, 2026
• Litchfield Hills Research Reiterates Buy Rating and $66 Price Target; Faraday Future Global CEO YT Jia and the Founding Team Affirm Their Commitment to Long-Term Share Ownership
• Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock